Cyclophosphamide
Product Images NDC 68001-563

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 68001-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (C7b7a033 56d0 4a09 Ae61 724be73f8114 01)

Chemical structure of Cyclophosphamide, showing its molecular components including a cyclic phosphoramide group and associated atoms, with a water molecule (H2O) noted.*

FDA Label Image

Cyclophosphamide Injection, 500mg/2.5ml Vial Label (C7b7a033 56d0 4a09 Ae61 724be73f8114 03)

Label for Cyclophosphamide Injection 500 mg/2.5 mL (200 mg/mL) by BluePoint Laboratories. The label indicates it is a cytotoxic agent that must be diluted before intravenous use, is a multiple-dose vial, and requires refrigeration. It includes storage instructions, active ingredient details, manufacturer information, and a barcode.*

FDA Label Image

Cyclophosphamide Injection 500mg/2.5ml Carton (C7b7a033 56d0 4a09 Ae61 724be73f8114 04)

Packaging label for Cyclophosphamide Injection 500 mg/2.5 mL (200 mg/mL) by BluePoint Laboratories. The multi-dose vial label includes storage instructions to refrigerate and warnings to dilute before intravenous use. The label also highlights the product as a cytotoxic agent and provides NDC 68001-563-84 along with manufacturer information.*

FDA Label Image

Cyclophophamide Injection 1g/5ml Vial Label (C7b7a033 56d0 4a09 Ae61 724be73f8114 05)

Label for Cyclophosphamide Injection 1 g/5 mL (200 mg/mL) by BluePoint Laboratories. The label indicates it is a multiple-dose vial, a cytotoxic agent, and must be diluted before intravenous use. It lists active ingredient amounts per mL and storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F). The label includes the NDC code 68001-564-22 and manufacturer information for Ingenus Pharmaceuticals, GmbH, Switzerland.*

FDA Label Image

Cyclophophamide Injection 1g/5 mL Carton (C7b7a033 56d0 4a09 Ae61 724be73f8114 06)

Packaging label for Cyclophosphamide Injection 1 g/5 mL (200 mg/mL) by BluePoint Laboratories. It includes storage instructions to refrigerate and a warning that the product must be diluted before intravenous use. The label indicates the product is a cytotoxic agent and is supplied as a multiple-dose vial. NDC 68001-564-22 is visible along with a barcode.*

FDA Label Image

Cyclophophamide Injection 2g/10ml Vial Label (C7b7a033 56d0 4a09 Ae61 724be73f8114 07)

Label for Cyclophosphamide Injection 200 mg/mL by BluePoint Laboratories. The label states it is a cytotoxic agent in a multiple-dose vial, requiring refrigeration and dilution before intravenous use. It includes manufacturer info for Ingenus Pharmaceuticals, Switzerland, and storage instructions, along with barcodes and lot/expiration date fields.*

FDA Label Image

Cyclophosphamide Injection 2g/10ml Carton (C7b7a033 56d0 4a09 Ae61 724be73f8114 08)

Packaging label for Cyclophosphamide Injection 2 g/10 mL (200 mg/mL) multiple-dose vial by BluePoint Laboratories. The label includes dosage strength, must dilute before intravenous use warnings, cytotoxic agent caution, storage instructions to refrigerate, and manufacturer information. Barcodes and NDC number 68001-565-28 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.